newsfilter
← Latest News
PR Newswire·

TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds

TC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic...